Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:1.4.3.13 (
lysyl oxidase
)
1,248
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Lysyl oxidase is the enzyme that is essential for collagen and elastin cross-linking. Previous investigations showed that
lysyl oxidase
is down-regulated in many human tumors and ras-transformed cells. Recently, we proved that antisense down-regulation of
lysyl oxidase
in NRK-49F cells induced phenotypic changes and oncogenic transformation, characterized by p21(ras) activation and
beta-catenin
/cyclin D1 up-regulation. In the present paper, we examined
beta-catenin
intracellular distribution and its association with E-cadherin. We observed an increased association between E-cadherin and
beta-catenin
in the lysyl-oxidase down-regulated cells during serum starvation. Moreover, we found that
beta-catenin
cytoplasmic and nuclear levels were increased, suggesting a failure of its down-regulation by the APC-GSK-3beta system, in particular the GSK-3beta phosphorylation of ser-33/37 and thr-41 of
beta-catenin
. Finally, we investigated the mechanisms leading to the observed cyclin D1 up-regulation. We showed that in the antisense
lysyl oxidase
cells the cyclin D1 promoter was activated through the LEF and the ATF/CRE sites in the proximal promoter. While the promoter activation through LEF is compatible with
beta-catenin
signaling, we investigated the possibility that the CRE-dependent activation might be linked to the down-regulation of
lysyl oxidase
. In fact, up-regulation of
lysyl oxidase
in a COS-7 cell model showed a significant diminution of the CREB protein binding to the cyclin D1 promoter, leading to a dramatic inhibition of its activity and a significant down-regulation of cyclin D1 protein level in vivo. Finally, our study describes some major anomalies occurring in
lysyl oxidase
down-regulated fibroblasts, related to
beta-catenin
signaling and cyclin D1 expression.
...
PMID:beta-catenin signaling and regulation of cyclin D1 promoter in NRK-49F cells transformed by down-regulation of the tumor suppressor lysyl oxidase. 1594 52